Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 201

    US appeals court declines J&J bid to stop sales of generic version of Blockbuster cancer drug Zytiga

    US appeals court declines J&J bid to stop sales of generic version of Blockbuster cancer drug Zytiga

    Medical Dialogues Bureau25 Nov 2018 9:24 AM IST
    New Delhi: A U.S. appeals court declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of...
    Indoco Remedies gets two minor observations from USFDA for Goa plants

    Indoco Remedies gets two minor observations from USFDA for Goa plants

    Medical Dialogues Bureau25 Nov 2018 9:07 AM IST
    Mumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....
    Novartis Luxturna Gene Therapy for restoring Eyesight in Rare retinal diseases gets European Approval

    Novartis Luxturna Gene Therapy for restoring Eyesight in Rare retinal diseases gets European Approval

    Medical Dialogues Bureau24 Nov 2018 1:24 PM IST
    Luxturna is first gene therapy for a genetic disease approved in both the U.S. and EU. Luxturna is first and only gene therapy approved in EU for...
    Samsung Electronics issues apology for factory cancer cases

    Samsung Electronics issues apology for factory cancer cases

    Medical Dialogues Bureau24 Nov 2018 1:18 PM IST
    South Korean activist group Sharps claims around 200 workers have fallen ill after working at Samsung plants and 70 of them have died subsequently.New...
    Roots and shoots: China seeks new markets for ancient medicines

    Roots and shoots: China seeks new markets for ancient medicines

    Medical Dialogues Bureau24 Nov 2018 9:24 AM IST
    New Delhi: Shanghai, Nov 21, 2018 -A crowd gathers at a Shanghai hospital, queuing for remedies made with plant mixtures and animal parts including...
    AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront

    AstraZeneca sells infant drug rights to Sobi for $1.5 bln upfront

    Medical Dialogues Bureau24 Nov 2018 9:00 AM IST
    LONDON: AstraZeneca took another step to refocus its portfolio on priority projects on Tuesday by selling U.S. rights to a treatment for a serious...
    Glenmark gets USFDA nod for pneumonia treatment drug

    Glenmark gets USFDA nod for pneumonia treatment drug

    Medical Dialogues Bureau23 Nov 2018 12:15 PM IST
    New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and...
    Zydus Cadila gets USFDA nod for generic cholesterol drug

    Zydus Cadila gets USFDA nod for generic cholesterol drug

    Garima23 Nov 2018 12:15 PM IST
    New Delhi: Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug...
    Microsoft Launcher 5.1 adds digital health features on Android

    Microsoft Launcher 5.1 adds digital health features on Android

    Medical Dialogues Bureau23 Nov 2018 9:55 AM IST
    Washington: Microsoft is not budging from introducing new tools and features to fight Google's popular services. In its latest attempt at luring more...
    HP: Integrated Health Information Platform- IHIP for Disease Surveillance launched

    HP: Integrated Health Information Platform- IHIP for Disease Surveillance launched

    Medical Dialogues Bureau23 Nov 2018 9:00 AM IST
    With the IHIP, All the authentic information required in the health department would be available in one place for ease of patients, data users as...
    Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

    Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

    Medical Dialogues Bureau22 Nov 2018 4:37 PM IST
    NEW DELHI: Piramal Enterprises on Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on...
    Lupin launches generic Tetrabenazine Tablets

    Lupin launches generic Tetrabenazine Tablets

    Medical Dialogues Bureau22 Nov 2018 4:26 PM IST
    Mumbai: Pharma major Lupin announced the launch of Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok